Good question.
They did perform baseline cognitive tests.
One of the exclusion criteria was:
"Inability to communicate well with the investigator (i.e. language problem, non-fluent English [as questionnaires and study drug label will be provided in English only], poor mental development or impaired cerebral function)."
Ann: Actinogen presents latest Xanamem data at AD Conference, page-65
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.002(8.33%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $327.7K | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3980679 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 412000 | 2 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |